Mabel Rios

BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile

L. Carvajal-Carmona, M. Camus, P. Carvallo, 2017, Oncotarget.

BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile.

L. Carvajal-Carmona, M. Camus, P. Carvallo, 2017, Oncotarget.

BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile

L. Carvajal-Carmona, M. Camus, P. Carvallo, 2017, Oncotarget.